Frontiers | IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate
![PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/306a583084d23ac2766f122cd384bf9952effebb/4-Figure2-1.png "PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar")
PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Hetero-intermediate Staphylococcus aureus
Aislamiento de Staphylococcus aureus hetero-resistente a vancomicina en Hospital Clínico Regional de Concepción, Chile
The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand | Journal of Clinical Microbiology
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected b
PDF) VISA, hetero-VISA and VRSA: the end of the vancomycin era?
![PDF] Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/258a27fe672f55293e8d301e8c6c1f3cdd58dc33/6-Figure8-1.png "PDF] Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. | Semantic Scholar")
PDF] Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. | Semantic Scholar
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
14th March 2013 Susceptibility testing for Vancomycin in S. aureus : What do we do now? Robin A Howe Antimicrobial use in Primary Care. - ppt download
Ceftaroline fosamil: drug profile and clinical data
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus - Document - Gale Academic OneFile
Detection of Staphylococcus aureus with reduced susceptibility to vancomycin in a South African teaching hospital
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections | Annals of Clinical Microbiology and Antimicrobials | Full Text
